Another evidence for superiority of anti-CCP-2 Ab as a good diagnostic marker in Saudi patients with RA in comparison with RF came from the study of Safi et al. [30] who found that a proportion (30.5%) of RF-negative RA patients, had positive anti-CCP-2 Ab serum levels. This evidence concerns the gene AGBL2 and rheumatoid arthritis.